A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
Clinical trial NCT01724177 · COMPLETED
Trial details
- NCT number
- NCT01724177
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-12
- Primary completion
- 2014-11-20
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.